Endonovo Therapeutics, Inc. (ENDV) stock
ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $135.08KP/E –Yield –
Endonovo Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Endonovo Therapeutics's total assets was $815.76K at Sep 30, 2023. For fiscal 2022 it was $1.28M, down 36.2% from the year before. Over ten years it grew 32.3% a year on average. The highest annual figure on record is $4.61M in fiscal 2017.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $1.28M | -36.2% |
| FY2021 | Dec 31, 2021 | $2.01M | -23.0% |
| FY2020 | Dec 31, 2020 | $2.61M | -20.4% |
| FY2019 | Dec 31, 2019 | $3.27M | -22.8% |
| FY2018 | Dec 31, 2018 | $4.24M | -8.0% |
| FY2017 | Dec 31, 2017 | $4.61M | +1347.3% |
| FY2016 | Dec 31, 2016 | $318.68K | -22.2% |
| FY2015 | Dec 31, 2015 | $409.36K | +797.9% |
| FY2014 | Dec 31, 2014 | $45.59K | -38.1% |
| FY2013 | Dec 31, 2013 | $73.59K | -5.8% |
| FY2012 | Dec 31, 2012 | $78.10K | -92.1% |
| FY2011 | Dec 31, 2011 | $993.57K | +491.6% |
| FY2010 | Dec 31, 2010 | $167.95K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | $815.76K | -43.8% |
| Q2 FY2023 | Jun 30, 2023 | $1.01M | -36.4% |
| Q1 FY2023 | Mar 31, 2023 | $1.20M | -33.9% |
| Q4 FY2022 | Dec 31, 2022 | $1.28M | -36.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.45M | -32.1% |
| Q2 FY2022 | Jun 30, 2022 | $1.59M | -29.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.82M | -28.0% |
| Q4 FY2021 | Dec 31, 2021 | $2.01M | -23.0% |
| Q3 FY2021 | Sep 30, 2021 | $2.14M | -21.8% |
| Q2 FY2021 | Jun 30, 2021 | $2.27M | -21.5% |
| Q1 FY2021 | Mar 31, 2021 | $2.52M | -17.8% |
| Q4 FY2020 | Dec 31, 2020 | $2.61M | -20.4% |
| Q3 FY2020 | Sep 30, 2020 | $2.73M | -20.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.90M | -29.8% |
| Q1 FY2020 | Mar 31, 2020 | $3.07M | -18.6% |
| Q4 FY2019 | Dec 31, 2019 | $3.27M | -22.8% |
| Q3 FY2019 | Sep 30, 2019 | $3.41M | -27.5% |
| Q2 FY2019 | Jun 30, 2019 | $4.12M | -3.8% |
| Q1 FY2019 | Mar 31, 2019 | $3.77M | -15.8% |
| Q4 FY2018 | Dec 31, 2018 | $4.24M | -8.0% |
| Q3 FY2018 | Sep 30, 2018 | $4.71M | +2840.4% |
| Q2 FY2018 | Jun 30, 2018 | $4.28M | +2006.3% |
| Q1 FY2018 | Mar 31, 2018 | $4.47M | +1147.6% |
| Q4 FY2017 | Dec 31, 2017 | $4.61M | +1347.3% |
| Q3 FY2017 | Sep 30, 2017 | $160.23K | -39.4% |
| Q2 FY2017 | Jun 30, 2017 | $203.39K | +98.6% |
| Q1 FY2017 | Mar 31, 2017 | $358.38K | -12.5% |
| Q4 FY2016 | Dec 31, 2016 | $318.68K | +393.2% |
| Q3 FY2016 | Sep 30, 2016 | $264.46K | +480.1% |
| Q1 FY2016 | Jun 30, 2016 | $102.43K | +39.2% |
| Q4 FY2015 | Dec 31, 2015 | $409.36K | +540.7% |
| Q1 FY2015 | Mar 31, 2015 | $64.61K | -12.6% |
| Q4 FY2014 | Dec 31, 2014 | $45.59K | -57.2% |
| Q4 FY2013 | Dec 31, 2013 | $73.59K | – |
| Q3 FY2013 | Sep 30, 2013 | $63.90K | – |
| Q2 FY2013 | Jun 30, 2013 | $73.92K | – |
| Q1 FY2013 | Mar 31, 2013 | $106.43K | – |
See a number that looks wrong?